Orion Portfolio Solutions LLC Cuts Position in Avantor, Inc. (NYSE:AVTR)

Orion Portfolio Solutions LLC lowered its position in Avantor, Inc. (NYSE:AVTR) by 0.5% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 149,758 shares of the company’s stock after selling 736 shares during the quarter. Orion Portfolio Solutions LLC’s holdings in Avantor were worth $3,829,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Fifth Third Bancorp raised its holdings in shares of Avantor by 125.3% in the 4th quarter. Fifth Third Bancorp now owns 1,248 shares of the company’s stock valued at $28,000 after purchasing an additional 694 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt raised its stake in Avantor by 565.5% in the fourth quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,331 shares of the company’s stock valued at $30,000 after buying an additional 1,131 shares in the last quarter. Gladius Capital Management LP acquired a new position in shares of Avantor during the 4th quarter worth about $42,000. Montag A & Associates Inc. acquired a new position in shares of Avantor during the 4th quarter worth about $43,000. Finally, TFO Wealth Partners LLC raised its position in shares of Avantor by 203,100.0% during the 4th quarter. TFO Wealth Partners LLC now owns 2,032 shares of the company’s stock worth $46,000 after acquiring an additional 2,031 shares in the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Analyst Upgrades and Downgrades

AVTR has been the topic of a number of research analyst reports. Robert W. Baird cut their price objective on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a report on Monday, April 29th. Citigroup cut shares of Avantor from a “buy” rating to a “neutral” rating and reduced their price target for the company from $30.00 to $23.00 in a research report on Wednesday, July 10th. Evercore ISI cut their target price on Avantor from $28.00 to $27.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 2nd. Deutsche Bank Aktiengesellschaft upped their target price on Avantor from $23.00 to $25.00 and gave the company a “hold” rating in a research report on Thursday, April 18th. Finally, Barclays cut their price target on Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research report on Friday, June 28th. Five analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $25.93.

Avantor Stock Performance

AVTR traded up $0.11 during trading on Friday, reaching $20.85. The company’s stock had a trading volume of 5,883,105 shares, compared to its average volume of 5,826,793. The company has a market capitalization of $14.16 billion, a price-to-earnings ratio of 53.44, a price-to-earnings-growth ratio of 2.19 and a beta of 1.32. The company’s fifty day moving average price is $22.70 and its 200-day moving average price is $23.62. Avantor, Inc. has a 52-week low of $16.63 and a 52-week high of $26.16. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.05 and a current ratio of 1.61.

Avantor (NYSE:AVTR) last issued its earnings results on Friday, April 26th. The company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.20 by $0.02. Avantor had a net margin of 3.79% and a return on equity of 13.01%. The company had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same period in the previous year, the firm earned $0.29 EPS. The business’s revenue was down 5.6% on a year-over-year basis. On average, equities analysts forecast that Avantor, Inc. will post 1.01 earnings per share for the current fiscal year.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.